,i #aagth ,,congress #ast ,session ,h4 ,r4 #dgeg ,,in ,,the ,,house ,,of ,,representatives ,july #bh1 #bjba,mr4 ,doggett 7for himself and ,ms4 ,de,lauro7 introduced the following bill2 which was referred to the ,committee on ,armed ,services1 and in addition to the ,committee on the ,judiciary1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to authorize the use of certain drugs1 vaccines1 and medical technologies to expand military and civilian access to such products1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,make ,taxpayer-,funded ,department of ,defense ,medical ,interventions ,affordable ,act4 #b4 ,authorization of use of drugs1 vaccines1 and medical technologies to expand military and civilian access to such products 7a7 ,report and identification of products ,not later than one year after the date of the enactment of this ,act1 the ,secretary of ,defense shall submit to the ,committees on ,armed ,services of the ,senate and the ,house of ,representatives a report on the efforts of the ,secretary to comply with the paragraph titled ,licensing of ,federally owned medical interventions1 included on page #agc of the report of the ,committee on ,armed ,services of the ,senate accompanying ,s4 #aeai of the #aaeth ,congress 7,s4 ,rept4 #aae-abe71 which shall include the following information3 7#a7 ,a description of what steps1 if any1 the ,secretary has taken to comply with such paragraph4 7#b7 ,a complete list of the drugs1 vaccines1 and medical technologies that1 as of the date of the enactment of this ,act1 meet the requirements outlined in such paragraph4 7#c7 ,for each drug1 vaccine1 or medical technology identified under paragraph 7#b71 a discussion of the plans of the ,secretary to utilize the authorities of the ,secretary under section #bjc or #bji7;d77#a7 of title #ce1 ,united ,states ,code1 to authorize a third party or ,federal agency to use the drug1 vaccine1 or medical technology4 7b7 ,authorization of use ,not later than one year after the date of the enactment of this ,act1 the ,secretary1 pursuant to section #bjc or #bji7;d77#a7 of title #ce1 ,united ,states ,code1 shall authorize third parties or ,federal agencies to use not fewer than #aj drugs1 vaccines1 or medical technologies identified under subsection 7a77#b7 for the purpose of expanding military and civilian access to such drugs1 vaccines1 or technologies4 #c4 ,department of ,defense database on support for biomedical research and development 7a7 ,database ,the ,secretary of ,defense shall-- 7#a7 compile into a searchable database information relating to any support provided before or after the date of enactment of this ,act by the ,department of ,defense1 or an entity acting on its behalf1 for biomedical research and development1 including with respect to drugs1 vaccines1 and medical technologies2 and 7#b7 make such database available on a public website of the ,department4 7b7 ,covered information ,the information relating to support described in subsection 7a77#a7 shall include all contracts1 funding agreements1 licensing arrangements1 other transactions1 and other arrangements entered into by1 or on behalf of1 the ,department of ,defense with respect to the research and development1 or the manufacturing and distribution1 of a drug 7including a biological product71 cell or gene therapy1 or medical device or other medical technology1 including the following3 7#a7 ,licensing agreements pursuant to section #bjg or #bji of title #ce1 ,united ,states ,code4 7#b7 ,cooperative research and development agreements and licensing agreements entered into pursuant to section #ab of the ,stevenson-,wydler ,technology ,innovation ,act of #aihj 7#ae ,u4,s4,c4 #cgaj;a74 7#c7 ,funding agreements1 as defined under section #bja of title #ce1 ,united ,states ,code4 7#d7 ,transactions1 contracts1 grants1 cooperative agreements1 other agreements1 and other arrangements entered into pursuant to the following authorities3 7,a7 ,section #bceh of title #aj1 ,united ,states ,code4 7,b7 ,section #bcga of such title4 7,c7 ,section #bcga;a of such title4 7,d7 ,section #bcga;b of such title4 7,e7 ,section #bcgc of such title4 7c7 ,information required ,notwithstanding any other provision of law1 the ,secretary shall include in the database under subsection 7a7 at a minimum1 with regard to each contract1 funding agreement1 licensing agreement1 other transaction1 or other arrangement1 described in subsection 7b71 the following information3 7#a7 ,the element of the ,department of ,defense providing the grant1 cooperative agreement1 or other support4 7#b7 ,the amount and period of financial support provided by the ,department1 with an itemized breakdown4 7#c7 ,other nonfinancial support provided by the ,department1 including the use of personnel1 facilities1 or equipment of the ,department4 7#d7 ,the grant number1 if applicable4 7#e7 ,associated clinical trial data1 upon trial completion4 7#f7 ,associated patents and patent applications1 specifying-- 7,a7 any ,department ownership in such patents and patent applications2 7,b7 the expiration date of such patents and filing dates of such patent applications2 and 7,c7 the numbers of such patents and patent applications4 7#g7 ,associated periods of marketing exclusivity under ,federal law and the durations of such periods4 7#h7 ,the corporation1 nonprofit organization1 academic institution1 person1 or other entity receiving the support provided by the ,department4 7#i7 ,any products 7including repurposed products7 approved1 authorized1 or cleared for marketing1 or for which marketing approval1 authorization1 or clearance is being sought1 the development of which was aided by support provided by the ,department1 including-- 7,a7 the names of such products2 7,b7 the prices of such products2 and 7,c7 the current and anticipated manufacturing capacity to produce such products4 7#aj7 ,the full terms of the contract1 funding agreement1 licensing agreement1 other transaction1 or other arrangement4 7d7 ,format of information ,the database under subsection 7a7 shall be-- 7#a7 searchable and filterable according to the categories of information described in subsection 7c72 and 7#b7 presented in a user-friendly format4 7e7 ,timing ,the database under subsection 7a7 shall be-- 7#a7 made publicly available not later than #cj days after the date of enactment of this ,act2 and 7#b7 updated not less frequently than once every two weeks4 7f7 ,disclosure 7#a7 ,in general ,notwithstanding any other provision of law1 to the extent necessary for the ,secretary to carry out this section1 the ,secretary may require entities receiving support as described in subsection 7a77#a7 to disclose to the ,secretary any information relating to such support and required to be included in the database under subsection 7a74 7#b7 ,intermediary cooperation ,any arrangement entered into by the ,department of ,defense with an entity providing for such entity to enter into contracts1 licensing agreements1 grants1 other transactions1 or other arrangements with third parties on behalf of the ,department shall require such entity to disclose in a timely manner any information necessary for the ,secretary of ,defense to fulfill the duties of the ,secretary under this ,act4 ,with respect to any such arrangement in place as of the date of enactment of this ,act1 the ,secretary may require the entity to disclose to the ,secretary any information required to be included in the database under subsection 7a74 7#c7 ,penalty for nondisclosure ,if an entity that is required to disclose information pursuant to paragraph 7#a7 or 7#b7 fails to disclose such information by the date that is two weeks after the date on which the ,secretary requests such information1 or by such reasonable deadline as the ,secretary may specify1 whichever is sooner1 then such entity shall be liable to the ,united ,states for a civil penalty in an amount not to exceed #aj1jjj for each day on which such failure continues4